Stem Cell Source Market Size and Growth Forecast: Global Insights and Analysis
Report ID : 1367555 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Stem Cell Source Market is categorized based on Cell Type (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells (iPSCs), Perinatal Stem Cells, Other Stem Cells) and Source (Bone Marrow, Adipose Tissue, Cord Blood, Peripheral Blood, Other Sources) and Application (Regenerative Medicine, Drug Discovery, Tissue Engineering, Cell Therapy, Other Applications) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
As of 2023, the Stem Cell Source Market size stood at 12.5 billion USD and is expected to attain 35.6 billion USD by 2033, growing at a 11.1% CAGR from 2024 through 2033. The report includes diverse segments and offers an analysis of trends and factors substantially impacting the market.
The Stem Cell Source Market is on the verge of changing medicine science as we know it and expanding businesses in ways that were not possible before. Industries are familiar with what stem cells are, so now with the integration of biotechnology and stem cells tissue engineering, the interest for stem cells procurable from umbilical cords, adipose tissues and bone marrow is exceptionally high. This market is not only expected to be a game-changer for various diseases and disorders, but also brings new intricacies and ethical issues that have to be dealt with.
Moving towards current times, the market is witnessing a substantial change due to the increased rate of chronic diseases, widening investment in R&D, and growing understand of stem cell treatment. Due to such changes, healthcare and biotechnology firms are working to better market themselves, which is why we are analyzing the intricacies of the stem cell source market, such as the major players, broad market structure, and relationships within the stem cell source market to help guide professionals to base calculations off of estimations.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Thermo Fisher Scientific, Lonza Group, Merck KGaA, R&D Systems, STEMCELL Technologies, Cytiva, Asterias Biotherapeutics, Cellerant Therapeutics, Osiris Therapeutics, Regenative Labs, AlloSource |
| SEGMENTS COVERED |
By Cell Type - Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells (iPSCs), Perinatal Stem Cells, Other Stem Cells
By Source - Bone Marrow, Adipose Tissue, Cord Blood, Peripheral Blood, Other Sources
By Application - Regenerative Medicine, Drug Discovery, Tissue Engineering, Cell Therapy, Other Applications
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Stem Cell Source Market Dynamics
The Stem Cell Source Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Stem Cell Source Market Segmentations
Market Breakup by Cell Type
- Overview
- Embryonic Stem Cells
- Adult Stem Cells
- Induced Pluripotent Stem Cells (iPSCs)
- Perinatal Stem Cells
- Other Stem Cells
Market Breakup by Source
- Overview
- Bone Marrow
- Adipose Tissue
- Cord Blood
- Peripheral Blood
- Other Sources
Market Breakup by Application
- Overview
- Regenerative Medicine
- Drug Discovery
- Tissue Engineering
- Cell Therapy
- Other Applications
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Stem Cell Source Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Thermo Fisher Scientific
- Lonza Group
- Merck KGaA
- R&D Systems
- STEMCELL Technologies
- Cytiva
- Asterias Biotherapeutics
- Cellerant Therapeutics
- Osiris Therapeutics
- Regenative Labs
- AlloSource
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved